Avantor Performance Materials Names New CEO
PTSM: Pharmaceutical Technology Sourcing and Management
Avantor Performance Materials appoints Michael Stubblefield as CEO.
Avantor Performance Materials, a manufacturer and supplier of high-performance chemistries, reported the appointment of Michael Stubblefield as CEO. Stubblefield has over 20 years of global chemical industry leadership experience. Most recently, Stubblefield served as a senior expert for the Chemicals Practice of McKinsey & Company.
In his role as CEO, Stubblefield will oversee all aspects of Avantor’s global operations in its four business areas, which include laboratory products, pharmaceuticals, electronic materials, and diagnostics. He will be based at Avantor’s corporate headquarters in Center Valley, PA. Stubblefield holds an MBA from Texas A&M University-Corpus Christi, and a Bachelor of Science degree in chemical engineering from the University of Utah.
Source: Avantor Performance Materials
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.
FDA Grants Full Approval for Symptomatic Tenosynovial Giant Cell Tumor Treatment
February 18th 2025Tenosynovial giant cell tumor (TGCT) is rare and non-malignant, forming in or near joints, but which if left untreated can cause damage to joints and surrounding tissue, potentially leading to significant disability.
